Natural Product: NPC474321

Natural Product IDNPC474321
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
2,3-Dihydroxypropyl (9E,11E)-13-Oxooctadeca-9,11-Dienoate
IUPAC Name 2,3-dihydroxypropyl (9E,11E)-13-oxooctadeca-9,11-dienoate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL465241
PubChem CID 10237201
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0000504] Lineolic acids and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey BABFYBAGZXSUDH-KDFHGORWSA-N
Standard InCHI InChI=1S/C21H36O5/c1-2-3-11-14-19(23)15-12-9-7-5-4-6-8-10-13-16-21(25)26-18-20(24)17-22/h7,9,12,15,20,22,24H,2-6,8,10-11,13-14,16-18H2,1H3/b9-7+,15-12+
SMILES CCCCCC(=O)/C=C/C=C/CCCCCCCC(=O)OCC(CO)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   368.26 Volume:   405.177
?
Van der Waals volume.
Dense:   0.909 LogP:   3.042
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.836
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.746
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   18.0 Rigid Bonds:   4.0
TPSA:   83.83
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   2.0 Rings:   0.0
Heavy Atoms:   5.0

MedChem Properties

QED Drug-Likeness Score:   0.176 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.063 Fsp3:   0.714
MCE-18:   3.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.171 Fluc inhibitor:   0.003
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.006
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.043
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.769 Promiscuous compounds:   0.253

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.12 MDCK Permeability:   -4.618
Pgp-inhibitor:   0.0 Pgp-substrate:   0.174
PAMPA:   0.699
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.019
20% Bioavailability (F20%):   0.743 30% Bioavailability (F30%):   0.883
50% Bioavailability (F50%):   0.935

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.245
Plasma Protein Binding (PPB):   94.43% Volume Distribution (VD):   -0.504
Fu: 6.156%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.026
OATP1B3 inhibitor:   0.979 BCRP inhibitor:   0.017
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   1.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.699
CYP2C9-inhibitor:   0.219 CYP2C9-substrate:   0.719
CYP2D6-inhibitor:   0.903 CYP2D6-substrate:   0.988
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.727
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.192 Half-life (T1/2):  0.657

ADMET: Toxicity

hERG Blockers:  0.165 hERG Blockers (10um):  0.437
Human Hepatotoxicity (H-HT):  0.376 Drug-induced Liver Injury (DILI):  0.042
AMES Toxicity:  0.566 Rat Oral Acute Toxicity:  0.021
Maximum Recommended Daily Dose:  0.114 Skin Sensitization:  0.988
Carcinogencity:  0.325 Eye Corrosion:  0.034
Eye Irritation:  0.729 Respiratory Toxicity:  0.067
Drug-induced Neurotoxicity:  0.052 Ototoxicity:  0.728
Hematotoxicity:  0.097 Drug-induced Nephrotoxicity:  0.669
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.037
A549 Cytotoxicity:  0.048 Hek293 Cytotoxicity:  0.109
BCF:   1.316
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.695
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.193
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.843
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33018 clitocybe clavipes Species Tricholomataceae Eukaryota n.a. n.a. n.a. PMID[12444711]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6555 Individual protein Aldehyde dehydrogenase 1, mitochondrial Saccharomyces cerevisiae Inhibition < 50.0 % PMID[21456549]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC474321 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.75 Intermediate Similarity NPC476654
0.75 Intermediate Similarity NPC476655
0.75 Intermediate Similarity NPC476656
0.7045 Intermediate Similarity NPC104537
0.6596 Remote Similarity NPC330426
0.6596 Remote Similarity NPC127091
0.6596 Remote Similarity NPC22101
0.6383 Remote Similarity NPC143857
0.6383 Remote Similarity NPC229252
0.6047 Remote Similarity NPC488257
0.6047 Remote Similarity NPC469937
0.6047 Remote Similarity NPC94699
0.6047 Remote Similarity NPC320588
0.6047 Remote Similarity NPC53463
0.6042 Remote Similarity NPC321919
0.5918 Remote Similarity NPC271921
0.5745 Remote Similarity NPC277597
0.56 Remote Similarity NPC209327
0.549 Remote Similarity NPC273508
0.5472 Remote Similarity NPC83965
0.54 Remote Similarity NPC475443
0.54 Remote Similarity NPC473829
0.5283 Remote Similarity NPC176215
0.5283 Remote Similarity NPC296436
0.52 Remote Similarity NPC476660
0.5094 Remote Similarity NPC48218
0.5094 Remote Similarity NPC141481
0.5094 Remote Similarity NPC464342

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474321 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data